Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
Clinical trial NCT01578668 · COMPLETED
Trial details
- NCT number
- NCT01578668
- Sponsor
- Guangzhou Medical University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2015-01-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.